Mizuho analyst Anthony Petrone raised the firm’s price target on Intuitive Surgical to $245 from $215 and keeps a Neutral rating on the shares. The analyst updated medtech and diagnostics models ahead of the Q4 earnings season to reflect feedback from last week’s West Coast broker conference and ongoing hospital/physician channel checks. The general tone suggested the elevated respiratory viral volumes did not impact inpatient volumes, although some pockets of weakness did emerge in outpatient elective procedures, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ISRG:
- Intuitive (NASDAQ:ISRG) Stock Falls on Weak Q4 Results
- Intuitive Announces Fourth Quarter Earnings
- Intuitive Surgical procedure outlook set conservatively, says Piper Sandler
- Intuitive Surgical sees Q4 revenue $1.66B, consensus $1.68B
- Intuitive Announces Preliminary Fourth Quarter and Full Year 2022 Results
